Building on a 2012 Nobel Prize-winning discovery, researchers are testing whether diseased cells in the eye can be reverted to young and healthy ones, and gave people a drug this year. Berly McCoy and Regina Barber talk with David Sinclair, David Furman, Sharon Rosenzweig-Lipson and Marco Quarta about what drives ageing, how epigenetic clocks estimate biological age and where they disagree, an age-reversal trial in the eye, a drug that targets senescent “zombie” cells, and whether treating the diseases of ageing could extend human lifespan or mainly healthy life.
Published Nov 11, 2026 · 14 min